EHA 2024: Updates in the Treatment of CLL - Episode 19
Nicole Lamanna, MD, offers expert insights on the emerging data for second-generation BCL2 inhibitors in relapsed/refractory chronic lymphocytic leukemia, highlighting recent advancements in the field.
Video content above is prompted by the following: